Loading...
Loading...
JP Morgan has downgraded Luminex
LMNX from Neutral to Underweight and maintains its $18 price target.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: DowngradesPrice TargetPre-Market OutlookAnalyst RatingsHealth CareJP MorganLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in